Mariella Bodemeier Loayza Careaga, PhD | Dec 4, 2023 | 6 min read
Haydeh Payami helped uncover the genetic basis of Parkinson’s disease. Now, she hopes to find new ways to treat the disease by studying the gut microbiome.
Data from mouse models for mild coronavirus infections and human tissue samples offer further evidence that it doesn’t take a severe infection—or even infection of brain cells at all—to cause long-term neurological symptoms.
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
Reports of the infection—including one death this month—recently shook up social media. But, unlike COVID-19, plague is a disease that countries have more or less got under control.
Rachael Moeller Gorman | Feb 28, 2022 | 10+ min read
The CDC has given the OK to lift indoor mask mandates in much of the US, and a growing number of states no longer require face coverings in schools. But most experts agree that masks slow school spread of SARS-CoV-2, and whether now is the right time to allow teachers and students to unmask is a matter of debate.
Sruthi S. Balakrishnan | Jun 1, 2021 | 10+ min read
Several labs have reported the formation of bacterial nanotubes under different, often contrasting conditions. What are these structures and why are they so hard to reproduce?
The symptoms suggest SARS-CoV-2 might infect neurons, raising questions about whether there could be effects on the brain that play a role in patients’ deaths, but the data are preliminary.